摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<(benzyloxy)carbonyl>-(2R)-amino-1-phenylbut-3-ene | 95832-30-7

中文名称
——
中文别名
——
英文名称
N-<(benzyloxy)carbonyl>-(2R)-amino-1-phenylbut-3-ene
英文别名
benzyl N-[(2R)-1-phenylbut-3-en-2-yl]carbamate
N-<(benzyloxy)carbonyl>-(2R)-amino-1-phenylbut-3-ene化学式
CAS
95832-30-7
化学式
C18H19NO2
mdl
——
分子量
281.354
InChiKey
GUBRGOFJDRRFAS-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    442.6±44.0 °C(Predicted)
  • 密度:
    1.095±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:4533bf9ff2847035af4a3f6db4fa7d4d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-<(benzyloxy)carbonyl>-(2R)-amino-1-phenylbut-3-ene lithium hydroxide 、 sodium hydroxide氢气silver(I) acetatesodium 、 potassium hydride 、 1-羟基苯并三唑三乙胺N,N'-二环己基碳二亚胺 作用下, 以 四氢呋喃甲醇乙醚二氯甲烷N,N-二甲基甲酰胺 为溶剂, 生成 乌苯美司
    参考文献:
    名称:
    碘代氨基甲酸酯从无环烯丙基胺立体控制合成(-)-贝斯他汀
    摘要:
    通过使用烯丙胺2和6描述了碘代氨基甲酸酯化反应的1,2-不对称诱导作用,该方法已成功地应用于Bestatin的立体控制合成中。
    DOI:
    10.1016/s0040-4039(01)91124-4
  • 作为产物:
    参考文献:
    名称:
    A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease
    摘要:
    The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1', S2, and S2' substrate-binding sites of HIV-1 protease are described. The synthesis of this series is highly flexible in the sense that the P1', P2, and P2' residues of the inhibitors can be changed independently. Molecular modeling studies on the phenyl ring of the P2 and P2' ligand suggested incorporation of hydrogen-bonding donor/acceptor groups at the 3' and 4-positions of the phenyl ring should increase binding potency. This led to the discovery of compound 7f (A-98881), which possesses high potency in the HIV-1 protease inhibition assay and the in vitro MT-4 cell culture assay (Ki = approximately 5 pM and EC50 = 0.002 microM). This compares well with the symmetrical cyclic urea 1 pioneered at DuPont Merck.
    DOI:
    10.1021/jm9507183
点击查看最新优质反应信息

文献信息

  • A novel process for the preparation of bestatin derivatives and intermediates thereof
    申请人:MICROBIAL CHEMISTRY RESEARCH FOUNDATION
    公开号:EP0156279A2
    公开(公告)日:1985-10-02
    The present invention relates to a new method of preparing bestatin derivatives of the formula wherein Ph is an optionally substituted phenyl group and Leu represents a leucine residue, and to an intermediate of the formula where Ph is as defined above.
    本发明涉及一种制备式中 Ph 为任选取代的苯基和 Leu 代表亮氨酸残基的贝他丁衍生物的新方法,以及式中 Ph 如上定义的中间体。
  • A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease
    作者:Hing L. Sham、Chen Zhao、Kent D. Stewart、David A. Betebenner、Shuqun Lin、Chang H. Park、Xiang-P. Kong、William Rosenbrook、Thomas Herrin、Darold Madigan、Suthida Vasavanonda、Nicholas Lyons、Akhter Molla、Ayda Saldivar、Kennan C. Marsh、Edith McDonald、Norman E. Wideburg、Jon F. Denissen、Terrel Robins、Dale J. Kempf、Jacob J. Plattner、Daniel W. Norbeck
    DOI:10.1021/jm9507183
    日期:1996.1.1
    The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1', S2, and S2' substrate-binding sites of HIV-1 protease are described. The synthesis of this series is highly flexible in the sense that the P1', P2, and P2' residues of the inhibitors can be changed independently. Molecular modeling studies on the phenyl ring of the P2 and P2' ligand suggested incorporation of hydrogen-bonding donor/acceptor groups at the 3' and 4-positions of the phenyl ring should increase binding potency. This led to the discovery of compound 7f (A-98881), which possesses high potency in the HIV-1 protease inhibition assay and the in vitro MT-4 cell culture assay (Ki = approximately 5 pM and EC50 = 0.002 microM). This compares well with the symmetrical cyclic urea 1 pioneered at DuPont Merck.
  • A stereocontrolled synthesis of (−)-bestatin from an acyclic allylamine by iodocyclocarbamation
    作者:Susumu Kobayashi、Toshiyuki Isobe、Masaji Ohno
    DOI:10.1016/s0040-4039(01)91124-4
    日期:1984.1
    1,2-Asymmetric induction of iodocyclocarbamation is described by using allylamines 2 and 6 and the method has been successfully applied to a stereocontrolled synthesis of bestatin.
    通过使用烯丙胺2和6描述了碘代氨基甲酸酯化反应的1,2-不对称诱导作用,该方法已成功地应用于Bestatin的立体控制合成中。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐